Results for:(169 found)
Dec 11, 2012 6:24PM on Top StocksBy Jim J. Jubak

There are better pipelines in the industry at a better price.

Tags: BMYPFE
Dec 3, 2012 12:25PM on Top StocksBy TheStreet Staff

But expect the Affordable Care Act and prescriber pushback to curb drug-pricing power.

Nov 19, 2012 1:11PM on Top StocksBy InvestorPlace

These stocks are ripe for a turnaround.

Nov 9, 2012 3:37PM on Top StocksBy Trefis

The approval of the rheumatoid arthritis treatment will help douse recent concerns about its pipeline.

Tags: ABTJNJPFE
Nov 8, 2012 11:08AM on Top StocksBy Stock Traders Daily

Can they also help boost the company's dormant stock?

Nov 7, 2012 10:17PM on Top StocksBy Gene Marcial

The market's tumble Wednesday following the president's reelection offers a fresh and real chance to ride the bull market.

Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

Oct 31, 2012 12:10PM on Top StocksBy TheStreet Staff

The second-generation HIV drug is being developed to counteract expiring patents.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.